FDA Okays First Generic Naloxone Spray, Will Prioritize Naloxone ANDAs

By Beth Wang / April 19, 2019 at 4:28 PM
FDA on Friday (April 19) approved the first generic naloxone nasal spray, commonly known as Narcan, for use in a community setting by people who do not have medical training. Moving forward, the agency also plans to prioritize review of applications for generic overdose-reversal drugs. While it’s unclear when the generic naloxone nasal spray, which is manufactured by Teva Pharmaceuticals, will be available on the market, the agency says the approval is a crucial step for the agency as it...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.